The University of South China, Hengyang, People's Republic of China.
Department of General Surgery, The First People's Hospital of Changde City, Changde, 415003, People's Republic of China.
BMC Surg. 2024 Mar 5;24(1):80. doi: 10.1186/s12893-024-02364-9.
Perineural invasion (PNI), as the fifth recognized pathway for the spread and metastasis of colorectal cancer (CRC), has increasingly garnered widespread attention. The preoperative identification of whether colorectal cancer (CRC) patients exhibit PNI can assist clinical practitioners in enhancing preoperative decision-making, including determining the necessity of neoadjuvant therapy and the appropriateness of surgical resection. The primary objective of this study is to construct and validate a preoperative predictive model for assessing the risk of perineural invasion (PNI) in patients diagnosed with colorectal cancer (CRC).
A total of 335 patients diagnosed with colorectal cancer (CRC) at a single medical center were subject to random allocation, with 221 individuals assigned to a training dataset and 114 to a validation dataset, maintaining a ratio of 2:1. Comprehensive preoperative clinical and pathological data were meticulously gathered for analysis. Initial exploration involved conducting univariate logistic regression analysis, with subsequent inclusion of variables demonstrating a significance level of p < 0.05 into the multivariate logistic regression analysis, aiming to ascertain independent predictive factors, all while maintaining a p-value threshold of less than 0.05. From the culmination of these factors, a nomogram was meticulously devised. Rigorous evaluation of this nomogram's precision and reliability encompassed Receiver Operating Characteristic (ROC) curve analysis, calibration curve assessment, and Decision Curve Analysis (DCA). The robustness and accuracy were further fortified through application of the bootstrap method, which entailed 1000 independent dataset samplings to perform discrimination and calibration procedures.
The results of multivariate logistic regression analysis unveiled independent risk factors for perineural invasion (PNI) in patients diagnosed with colorectal cancer (CRC). These factors included tumor histological differentiation (grade) (OR = 0.15, 95% CI = 0.03-0.74, p = 0.02), primary tumor location (OR = 2.49, 95% CI = 1.21-5.12, p = 0.013), gross tumor type (OR = 0.42, 95% CI = 0.22-0.81, p = 0.01), N staging in CT (OR = 3.44, 95% CI = 1.74-6.80, p < 0.001), carcinoembryonic antigen (CEA) level (OR = 3.13, 95% CI = 1.60-6.13, p = 0.001), and platelet-to-lymphocyte ratio (PLR) (OR = 2.07, 95% CI = 1.08-3.96, p = 0.028).These findings formed the basis for constructing a predictive nomogram, which exhibited an impressive area under the receiver operating characteristic (ROC) curve (AUC) of 0.772 (95% CI, 0.712-0.833). The Hosmer-Lemeshow test confirmed the model's excellent fit (p = 0.47), and the calibration curve demonstrated consistent performance. Furthermore, decision curve analysis (DCA) underscored a substantial net benefit across the risk range of 13% to 85%, reaffirming the nomogram's reliability through rigorous internal validation.
We have formulated a highly reliable nomogram that provides valuable assistance to clinical practitioners in preoperatively assessing the likelihood of perineural invasion (PNI) among colorectal cancer (CRC) patients. This tool holds significant potential in offering guidance for treatment strategy formulation.
神经周围侵犯(PNI)作为结直肠癌(CRC)第五种公认的转移途径,越来越受到广泛关注。术前识别结直肠癌(CRC)患者是否存在 PNI 有助于临床医生增强术前决策,包括确定新辅助治疗的必要性和手术切除的适当性。本研究的主要目的是构建和验证一种用于评估诊断为结直肠癌(CRC)患者发生神经周围侵犯(PNI)风险的术前预测模型。
在一家医疗中心,对 335 名被诊断为结直肠癌(CRC)的患者进行随机分组,221 名患者被分配到训练数据集,114 名患者被分配到验证数据集,比例为 2:1。仔细收集了全面的术前临床和病理数据进行分析。初始探索包括进行单变量逻辑回归分析,随后将显示 p<0.05 水平的变量纳入多变量逻辑回归分析,以确定独立的预测因素,同时保持 p 值阈值<0.05。从这些因素中,精心设计了一个列线图。通过接受者操作特征(ROC)曲线分析、校准曲线评估和决策曲线分析(DCA),对该列线图的精度和可靠性进行了严格评估。通过应用bootstrap 方法进一步增强了稳健性和准确性,该方法涉及 1000 次独立数据集抽样,以进行判别和校准程序。
多变量逻辑回归分析揭示了结直肠癌(CRC)患者发生神经周围侵犯(PNI)的独立风险因素。这些因素包括肿瘤组织学分化(分级)(OR=0.15,95%CI=0.03-0.74,p=0.02)、原发肿瘤位置(OR=2.49,95%CI=1.21-5.12,p=0.013)、大体肿瘤类型(OR=0.42,95%CI=0.22-0.81,p=0.01)、CT 中的 N 分期(OR=3.44,95%CI=1.74-6.80,p<0.001)、癌胚抗原(CEA)水平(OR=3.13,95%CI=1.60-6.13,p=0.001)和血小板与淋巴细胞比值(PLR)(OR=2.07,95%CI=1.08-3.96,p=0.028)。这些发现构成了构建预测列线图的基础,该列线图的接受者操作特征(ROC)曲线下面积(AUC)为 0.772(95%CI,0.712-0.833),表现出色。Hosmer-Lemeshow 检验证实了模型的优异拟合(p=0.47),校准曲线显示出一致的性能。此外,决策曲线分析(DCA)强调了在 13%至 85%的风险范围内具有显著的净获益,通过严格的内部验证进一步证实了列线图的可靠性。
我们制定了一个高度可靠的列线图,为临床医生术前评估结直肠癌(CRC)患者发生神经周围侵犯(PNI)的可能性提供了有价值的帮助。该工具在指导治疗策略制定方面具有重要潜力。